Acclaimed oncologist from Roswell Park Comprehensive Cancer Center to help lead nonprofit responsible for gold standard guidelines that define and advance cancer care worldwide.
PLYMOUTH MEETING, Pa., Dec. 4, 2025 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers that publishes free evidence-based, expert consensus-driven guidelines for cancer prevention and care—today announced the hiring of Renuka Iyer, MD, as the new Chief Medical Officer (CMO) for the organization.
Dr. Iyer has a long history of leadership and innovation in oncology. She currently serves as a Professor of Oncology for Roswell Park Comprehensive Cancer Center—one of NCCN's Member Institutions—as well as Section Chief of Gastrointestinal Oncology and Vice Chair of Faculty Affairs in Roswell Park's Department of Medicine, and Medical Director for Medical Oncology across the Roswell Park Care Network. She also serves as a Professor of Medicine at Jacobs School of Medicine at the University of Buffalo.
Fellowship-trained in medical oncology at Roswell Park, Dr. Iyer attended Grant Medical College at the University of Mumbai, followed by residency at Cornell University School of Medicine. She is board certified in internal medicine and oncology; a member of numerous professional societies; the recipient of several awards from organizations that include the North American Neuroendocrine Tumor Society, The Cholangiocarcinoma Foundation, and American Cancer Society; and has published hundreds of peer-reviewed articles, abstracts, and book chapters. Her research focuses on novel therapies for rare cancers, immunotherapy, biomarkers, and quality of life.
"Renuka is the perfect person to take on such an important role impacting treatment and outcomes for people with cancer around the world," said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN. "Over the years, she has shown a remarkable commitment to advancing research and improving care so all people can live better lives. She has devoted her career to driving innovations and putting them into practice. Renuka has been a major contributor to NCCN's mission for years; we look forward to seeing what she will do to enhance access to high-quality, high-value, patient-centered cancer care in the future."
Dr. Iyer has served as a member of the NCCN Guidelines Steering Committee since 2023. As a Steering Committee member, she helps provide strategic oversight to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) program, including assigning subject matter experts to panels and advising NCCN regarding future direction. Prior to that, she served as a panelist for the NCCN Guidelines® Panels for Occult Primary Cancer and Hepatobiliary Cancer, in addition to serving on other professional organization guidelines panels.
In her new role as NCCN CMO, Dr. Iyer will play an even larger role with the NCCN Guidelines program, which consists of 90 guidelines for treating nearly every type of cancer, along with prevention, screening, and supportive care. Each of the NCCN Guidelines is updated at least once per year and often far more frequently than that. They are available in multiple formats, including via the new, interactive NCCN Guidelines Navigator™.
Dr. Iyer's work will include clinical leadership for the NCCN Guidelines program and oversight for additional point-of-care resources based on the NCCN Guidelines, including the Library of NCCN Compendia. She will also oversee NCCN's Continuing Education (CE) department, JNCCN—Journal of the National Comprehensive Cancer Network, and participate in Global and Policy efforts.
"I am honored to be chosen for this prestigious position and excited to be at NCCN during a time when there are so many updates and opportunities to innovate how we deliver information to help our patients," said Dr. Iyer. "After 21 years in academic oncology, I welcome the opportunity to advance high-quality cancer care and to help build bridges to further the NCCN mission."
Dr. Iyer's first day as CMO will be February 26, 2026.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is marking 30 years as a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Renuka Iyer, MD, Named New Chief Medical Officer for National Comprehensive Cancer Network (NCCN)
Renuka Iyer, MD, Named New Chief Medical Officer for National Comprehensive Cancer Network (NCCN)
SHENZHEN, China, April 1, 2026 /PRNewswire/ -- On March 30, Delonix Group presented two new initiatives at its 2026 strategy conference: Genie AI, embedded in its Betterwood App, and a customer experience framework known as the Heavenly Stems & Earthly Branches Model.
Individually, they resemble product and service upgrades. Taken together, they suggest something more structural: an attempt to replace the logic on which the hospitality industry has operated for decades.
For most of its modern history, the sector has been governed by a simple equation—growth through physical expansion. More rooms, better locations, higher occupancy. Scale was both strategy and moat.
That equation is beginning to break.
Chairman Zheng Nanyan framed the shift not as cyclical, but structural. The convergence of maturing consumer expectations and rapidly deployable AI systems is eroding the effectiveness of asset-led growth. Standardization, once a tool for efficiency, now produces indistinguishable experiences. Capital intensity, long tolerated, is becoming a constraint.
What is emerging in its place is not a more efficient version of the same model, but a different organizing principle altogether: demand, not supply, as the system's point of origin.
From Capacity to Interpretation
In this emerging model, the central problem is no longer how to build and fill capacity, but how to interpret and respond to fragmented, real-time customer intent.
This is where Delonix is positioning Genie AI.
Unlike most applications of AI in hospitality—which tend to sit at the interface level—Genie AI is designed to sit in the middle of the system, between intent and execution. It does not simply respond to requests; it structures them.
A guest interaction—whether through app input or voice—is translated into a sequence of executable tasks, routed through a centralized decision layer, and distributed to the nearest available human resource, before feeding back into the system as data.
The technical architecture is not unprecedented. What is notable is the ambition to make it foundational.
If it works as intended, service ceases to be a function of individual responsiveness and becomes instead a property of the system itself. Variability, historically managed after the fact, is designed out at the level of coordination.
In that sense, AI is no longer augmenting service. It is defining its boundaries.
Standardization Was the Solution. Now It Is the Constraint.
The industry's previous growth model depended on standardization: replicable rooms, predictable services, consistent delivery across locations. This enabled scale, but at the cost of differentiation.
As consumer expectations evolve, that trade-off is becoming less acceptable.
Delonix's response is not to abandon standardization, but to layer variability on top of it—systematically.
The Heavenly Stems & Earthly Branches Model introduces a framework in which products and services are no longer fixed configurations, but evolving modules. Customer interaction becomes an input into how the product itself is iterated over time.
The implication is subtle but significant.
Hotels are no longer static assets with service attached. They become adaptive systems, where the product is continuously reshaped by usage.
For customers, this promises a form of progression—an experience that accumulates rather than resets. For operators and investors, it suggests a shift from one-off capital deployment to ongoing, incremental reconfiguration.
In both cases, the underlying assumption is the same: value is not embedded in the asset, but generated through interaction.
Control Shifts to the System Layer
What ties these elements together is not technology alone, but control.
In the traditional model, control resided in assets—ownership, location, physical scale. In the emerging model, it moves upward, into the system layer that interprets demand, allocates resources, and continuously adjusts the product.
This shift has implications beyond efficiency.
A system that can interpret intent, coordinate execution, and learn from outcomes begins to set the terms of competition. The advantage no longer lies in having more assets, but in having a better system for deciding how those assets are used.
In that sense, AI is not just infrastructure. It is governance.
An Industry at the Edge of Repricing
China's broader push to integrate AI into industrial and consumer systems provides the backdrop for this shift. Policy frameworks such as the State Council's "AI+" initiative are accelerating deployment, but the more consequential changes are happening at the level of business models.
Hospitality is one of the more exposed sectors.
As the marginal return on physical expansion declines, and as customer expectations become more fluid, the industry is moving toward a repricing of what constitutes value. Scale, once the primary moat, is becoming easier to replicate and harder to defend.
What replaces it is still being defined.
Delonix's approach offers one possible direction: treating demand as a continuously generated input, and building systems capable of capturing and compounding it. Whether this model proves durable remains to be seen. But its premise is clear.
The future of hospitality may depend less on how hotels are built, and more on how they think.
About Delonix Group
Delonix Group is a leading international hospitality and experiential consumption group in the Asia-Pacific region. Ranked 14th globally, the Group partnered with Marriott International to launch the world's first dual-branded luxury property: MajesTang Hotel • A Tribute Portfolio Hotel, while independently creating MaisonLee, a Tang-inspired premium business travel brand. As one of the first Chinese hotel groups to expand overseas, Delonix has established a presence in high-potential markets such as Japan and Indonesia, now spanning more than 200 cities worldwide. Its portfolio encompasses Swiss-Belhotel, Artotel, Model J, hotel MONday, and other brands, positioning the Group at the forefront of building a new generation global platform for high-end hospitality and culturally immersive travel.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
When Demand Becomes the System: Delonix and the Rewriting of Hospitality's Operating Logic
